Qing Zhong - Publications

Beyond TNM staging: validation of a CT-derived nutritional-inflammatory composite model (RFMmSIS) for prognostication in resectable gastric cancer.

Journal: BMC cancer

Published: May 01, 2026

Multimodal features and prognostic risk assessment in locally advanced gastric cancer patients following neoadjuvant therapy based on machine learning algorithms: a multicenter study.

Journal: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association

Published: March 04, 2026

Immune-inflammatory-fibrinogen score as a novel prognostic biomarker in patients with gastric cancer undergoing radical gastrectomy: a multicenter study.

Journal: World journal of surgical oncology

Published: February 07, 2026

Tff2 marks gastric corpus progenitors that give rise to pyloric metaplasia/SPEM following injury.

Journal: Gut

Published: December 16, 2025

Midkine-activated TRPA1+ cancer-associated fibroblasts promote immunotherapy resistance in gastric cancer through a WNT5A-mediated treg circuit.

Journal: Oncogene

Published: November 29, 2025

Modified gastric cancer ypTNM staging based on optimized lymph node staging: A large-sample, international multicenter study.

Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

Published: October 30, 2025

Recurrence outcome and prediction model of patients with gastric cancer underwent laparoscopic-assisted total gastrectomy: A retrospective study.

Journal: Surgery

Published: July 09, 2025

Recurrence outcomes of robotic versus laparoscopic surgery for gastric cancer: A multicenter study.

Journal: iScience

Published: June 17, 2025

Dynamic postoperative prognosis and follow-up optimization for gastric cancer patients after neoadjuvant therapy: a multicenter retrospective study.

Journal: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association

Published: June 13, 2025

Long-term oncological outcomes of indocyanine green fluorescence imaging-guided laparoscopic lymphadenectomy for gastric cancer: 5-year outcomes from the FUGES-012 randomized clinical trial.

Journal: BMC medicine

Published: May 06, 2025

Tff2 marks gastric corpus progenitors that give rise to pyloric metaplasia/SPEM following injury.

Journal: bioRxiv : the preprint server for biology

Published: April 28, 2025

RBM17 promotes hepatocellular carcinoma progression by regulating lipid metabolism and immune microenvironment: implications for therapeutic targeting.

Journal: Cell death discovery

Published: March 25, 2025